Middle East & Africa Antiarrhythmic Drugs Market Size & Outlook
Related Markets
MEA antiarrhythmic drugs market highlights
- The MEA antiarrhythmic drugs market generated a revenue of USD 43.3 million in 2024.
- The market is expected to grow at a CAGR of 5.3% from 2025 to 2030.
- In terms of segment, beta blockers was the largest revenue generating drug class in 2024.
- Potassium Channel Blockers is the most lucrative drug class segment registering the fastest growth during the forecast period.
- Country-wise, Kuwait is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 43.3 million |
| Market revenue in 2030 | USD 59.0 million |
| Growth rate | 5.3% (CAGR from 2025 to 2030) |
| Largest segment | Beta blockers |
| Fastest growing segment | Potassium Channel Blockers |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Potassium Channel Blockers, Sodium Channel Blockers, Beta Blockers, Calcium Channel Blockers, Other Drug Class |
| Key market players worldwide | Pfizer Inc, Novartis AG ADR, Viatris Inc, Baxter International Inc, Sanofi SA, GlaxoSmithKline Consumer Healthcare (GSK CH India), Mayne Pharma Group Ltd, Bora Pharmaceuticals, Merck KGaA |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.9% of the global antiarrhythmic drugs market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 412.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antiarrhythmic Drugs Market Scope
Antiarrhythmic Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Mayne Pharma Group Ltd | View profile | 160 | 1538 Main North Road, Salisbury South, Salisbury, SA, Australia, 5106 | http://www.maynepharma.com |
| Bora Pharmaceuticals | View profile | 501-1000 | Taipei, T'ai-pei, Taiwan, Asia | http://www.bora-corp.com/ |
| GlaxoSmithKline Consumer Healthcare (GSK CH India) | View profile | 1001-5000 | Gurgaon, Haryana, India, Asia | https://india-consumer.gsk.com/ |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Middle East & Africa antiarrhythmic drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antiarrhythmic drugs market will help companies and investors design strategic landscapes.
Beta blockers was the largest segment with a revenue share of 36.72% in 2024. Horizon Databook has segmented the Middle East & Africa antiarrhythmic drugs market based on potassium channel blockers, sodium channel blockers, beta blockers, calcium channel blockers, other drug class covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Middle East & Africa antiarrhythmic drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa antiarrhythmic drugs market databook
-
Our clientele includes a mix of antiarrhythmic drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa antiarrhythmic drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa antiarrhythmic drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA antiarrhythmic drugs market size, by country, 2018-2030 (US$M)
Middle East & Africa Antiarrhythmic Drugs Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
